Similar articles

• Prevention of prostate cancer with finasteride.

  Ross RK, Skinner E, Cote RJ. Ross RK, et al. N Engl J Med. 2003 Oct 16;349(16):1569-72; author reply 1569-72. N Engl J Med. 2003. PMID: 14562807 No abstract available.
• Therapeutic effects of finasteride: inhibition of disease progression and serum prostate-specific antigen reduction in patients with prostatic intraepithelial neoplasia.

  He JW, Huang ZX, Wu JL, Su YF, Xu XL. He JW, et al. Ann Biol Clin (Paris). 2024 Feb 24;81(6):610-620. doi: 10.1684/abc.2023.1859. Ann Biol Clin (Paris). 2024. PMID: 38391166
• Finasteride decreases the risk of prostatic intraepithelial neoplasia.

  Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA. Thompson IM, et al. J Urol. 2007 Jul;178(1):107-9; discussion 110. doi: 10.1016/j.juro.2007.03.012. Epub 2007 May 11. J Urol. 2007. PMID: 17499284 Clinical Trial.
• [Is tumour grade applicable to finasteride-treated prostate cancer?].

  Molinié V, Ruffion A, Allory Y, Leroy X, Cochand Priollet B, Paraf F, de la Taille A. Molinié V, et al. Prog Urol. 2005 Jun;15(3):387-91. Prog Urol. 2005. PMID: 16097140 Review. French.
• Does finasteride alter the pathology of the prostate and cancer grading?

  Bostwick DG, Qian J, Civantos F, Roehrborn CG, Montironi R. Bostwick DG, et al. Clin Prostate Cancer. 2004 Mar;2(4):228-35. doi: 10.3816/cgc.2004.n.004. Clin Prostate Cancer. 2004. PMID: 15072606 Review.